Safety Alerts Saves Lives
Safety Alerts  
Home Privacy About Us Contact Us Change Preferences
" "
Safety Alerts
September 14, 1999

Tavist D Tablets, Antihistamine/Nasal Decongestant Recalled by Novartis Consumer Health, Inc.

Lincoln, NE (SafetyAlerts) - The Food and Drug Administration (FDA) today reported that Novartis Consumer Health, Inc. is recalling Tavist D Tablets because of dissolution failure - Clemastine Fumarate (12 month stability test station).

Tavist D Tablets, Antihistamine/Nasal Decongestant, (Clemastine Fumarate, USP 1.34 mg/Phenylpropanolamine HCL, USP 75mg), 8 and 48 tablet units.

Recall #D-408-9.  Class III

Lot numbers: 200145 EXP 10/2000 and 200146 EXP 10/2000.

Novartis Consumer Health, Inc., Lincoln, Nebraska.

Manufacturer, by letter dated June 7, 1999. Firm-initiated recall ongoing.


243,108 8-tablet packages and 40,680 48-tablet packages were distributed.

Safety Alerts compiles comprehensive safety recall information for the United States. SafeMail is a free email service to warn consumers of faulty products and contaminated foods. For complete information regarding current recalls, past recalls and timely product warning notification visit:



The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.